��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
正達(3149)
月營收
季盈餘
2025/02/01
35.45元 (正達股價)
2025/02/01
12.81% (年增率)
101百萬元 (營收)
正達(3149) 年度營收走勢圖
正達(3149)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/02
100,543
-43.83%
89,129
12.81%
279,541
9.88%
114/01
178,998
0.67%
165,282
8.30%
178,998
8.30%
113/12
177,812
-11.07%
168,112
5.77%
2,163,181
16.36%
113/11
199,957
18.66%
160,557
24.54%
1,985,368
17.41%
113/10
168,518
-26.45%
165,786
1.65%
1,785,412
16.67%
113/09
229,111
10.78%
159,050
44.05%
1,616,894
18.49%
113/08
206,819
1.69%
162,737
27.09%
1,387,783
15.12%
113/07
203,386
0.13%
164,089
23.95%
1,180,964
13.25%
113/06
203,112
2.20%
163,768
24.02%
977,578
11.25%
113/05
198,739
22.05%
156,135
27.29%
774,466
8.33%
113/04
162,836
2.75%
162,731
0.06%
575,727
3.03%
113/03
158,480
77.81%
170,195
-6.88%
412,891
4.25%
113/02
89,129
-46.07%
111,034
-19.73%
254,411
12.63%
113/01
165,282
-1.68%
114,844
43.92%
165,282
43.92%
112/12
168,112
4.71%
155,807
7.90%
1,859,040
-23.50%
112/11
160,557
-3.15%
232,136
-30.83%
1,690,928
-25.65%
112/10
165,786
4.24%
222,310
-25.43%
1,530,371
-25.06%
112/09
159,050
-2.27%
213,629
-25.55%
1,364,585
-25.02%
112/08
162,737
-0.82%
229,172
-28.99%
1,205,535
-24.95%
112/07
164,089
0.20%
224,365
-26.87%
1,042,798
-24.28%
112/06
163,768
4.89%
238,968
-31.47%
878,709
-23.77%
112/05
156,135
-4.05%
200,280
-22.04%
714,941
-21.76%
112/04
162,731
-4.39%
218,359
-25.48%
558,805
-21.68%
112/03
170,195
53.28%
159,002
7.04%
396,074
-20.01%
112/02
111,034
-3.32%
120,558
-7.90%
225,879
-32.81%
112/01
114,844
-26.29%
215,615
-46.74%
114,844
-46.74%
111/12
155,807
-32.88%
224,176
-30.50%
2,430,202
-7.03%
111/11
232,136
4.42%
236,559
-1.87%
2,274,395
-4.82%
111/10
222,310
4.06%
207,742
7.01%
2,042,258
-5.15%
111/09
213,629
-6.78%
225,271
-5.17%
1,819,948
-6.45%
111/08
229,172
2.14%
208,617
9.85%
1,606,319
-6.61%
111/07
224,365
-6.11%
240,766
-6.81%
1,377,146
-8.89%
111/06
238,968
19.32%
258,431
-7.53%
1,152,781
-9.28%
111/05
200,280
-8.28%
195,458
2.47%
913,813
-9.73%
111/04
218,359
37.33%
192,395
13.50%
713,533
-12.64%
111/03
159,002
31.89%
216,847
-26.68%
495,174
-20.70%
111/02
120,558
-44.09%
164,251
-26.60%
336,172
-17.52%
111/01
215,615
-3.82%
215,615
110/12
224,176
-5.23%
2,613,833
110/11
236,559
13.87%
2,389,657
110/10
207,742
-7.78%
2,153,097
110/09
225,271
7.98%
1,945,355
110/08
208,617
-13.35%
1,720,084
110/07
240,766
-6.84%
1,511,467
110/06
258,431
32.22%
1,270,701
110/05
195,458
1.59%
1,012,270
110/04
192,395
-11.28%
816,812
110/03
216,847
32.02%
624,417
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
